The drug discovery and pharma companies have extended their agreement to collaborate on development of new treatments for a range of therapeutic areas.
A recent study from the clinical research services firm indicates the pandemic continues to significantly impact clinical trial sites around the globe.
The US agency continues to issue advice for life-sciences professionals engaged in work related to the virus, and keep an eye out for fraudulent products.
A leader from Iqvia will present an overview of artificial intelligence, machine learning and other \technology during this year’s CPhI Festival of Pharma.
The technology from Opyl uses artificial intelligence to anticipate a COVID-19 treatment, vaccine, diagnostic or device’s chances of success in a study.
A leader from the clinical trial technology firm shares how direct data capture and other solutions can address the unique needs of such complex studies.
Merck and Seattle Genetics have announced two strategic oncology collaborations: one to develop Seattle Genetics’ antibody-drug conjugate ladiratuzumab vedotin worldwide; and another to accelerate the global reach of Tukysa (tucatinib).
The company is delving into clinical research partnerships geared toward saving the lives of soldiers, eventually translating findings to civilian care.
The company’s Medidata Detect centralized trial monitoring solution is designed to improve management of data quality, site monitoring and patient safety.
Innovative research by Tabula Rasa Healthcare uses simulation technology to analyze potential adverse drug events of potential therapies for the virus.
The pharma firm and health association plan to collaborate in order to help drive global action toward prevention and control of cardiovascular disease.
The companies will work together on solutions designed to enable sponsors to improve imaging, respiratory and cardiac safety data on decentralized trials.
The company has released a report revealing how clinical trial professionals are handling start-up, before and after COVID-19 first impacted the industry.
Led by the Spaulding Rehabilitation Hospital, a study by a 60-person task force shows ways mobile health tech can help mitigate the pandemic’s effects.
